INSERM Group Examines Use of In Vivo Microscopic Imaging Technology in Pancreatic Cancer

The INSERM research group at the Institute of Research against Digestive Cancer used a new, in vivo microscopic imaging technology to develop a technique that may help improve outcomes of surgery to remove pancreatic cancer, according to a news release from Mauna Kea Technologies.

Advertisement

The team at IRCAD used Mauna Kea’s Cellvizio probe-based Confocal Laser Endomicroscopy system, a miniaturized, flexible, fiber-optic microscope, to aid in the identification of malignant tissue and metastases in the pancreas and surrounding lymph nodes while operating.

In the study, IRCAD researchers used the Cellvizio system to assist in the detection of cancerous cells in the pancreas and surrounding lymph nodes in laboratory rats. The study also showed that the team was able to identify very small metastases that had been initially missed with traditional techniques with Cellvizio, according to the release.

The pre-clinical data from the study is published in the November issue of the American Journal Gastroenterology.

Read the release on the Cellvizio system.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.